Burd A, Levine RL, Shoben A, et al. Initial Report of the Beat AML Umbrella study for previously untreated AML: evidence of feasibility and early success in molecularly driven phase 1 and 2 studies. ASH Annual Meeting and Exposition 2018, abstract 559.
Inotuzumab ozogamicine als inductie bij patiënten > 55 jaar met Ph-negatieve precursor B-ALL
jan 2024 | Leukemie